Product
CT0594CP
1 clinical trial
2 indications
Indication
Multiple MyelomaIndication
Plasma Cell LeukemiaClinical trial
Exploratory Study to Assess the Safety and Efficacy of CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell LeukemiaStatus: Recruiting, Estimated PCD: 2026-04-29